Startup for bio-manufacturing of high value-added inputs, with bioprinting and genetic engineering as key technologies. The first of these inputs is ultra-pure human bioidentical collagen type 1, applicable initially to the dermal filler industry and expandable to other applications, from regenerative medicine to cosmetics.
BUSINESS MODEL: Based on the commercialization of innovative raw materials, such as collagen in a bioidentical format to human collagen. For co-development of products in partnership with the industry, the model of royalties is adopted.
PRODUCT: In development
For further information, please contact us.
Back to Investors page